Blockade of ICAM-1: A novel way of vasculitis treatment

被引:11
作者
Xu, Youhua [1 ]
Li, Shengnan [1 ]
机构
[1] Nanjing Med Univ, Dept Pharmacol, Nanjing 210029, Peoples R China
关键词
Vasculitis; Intercellular adhesion molecule-1; Inflammation; Therapy; INTERCELLULAR-ADHESION MOLECULE-1; INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; SYSTEMIC VASCULITIS; ENDOTHELIAL-CELLS; E-SELECTIN; TNF-ALPHA; EXPRESSION; ATHEROSCLEROSIS; VCAM-1;
D O I
10.1016/j.bbrc.2009.02.111
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vasculitis is becoming more common worldwide, but there is no effective therapeutic method towards this series of disease till now. Intercellular adhesion molecule (ICAM)-1 is one of an important cell adhesion molecules (CAMs) family glycoprotein that plays pivotal role in inflammation process and participates in vasculitis. Blockade of ICAM-1 has been witnessed with its satisfactory effect on inflammatory disease treatment. Therefore, this method may be considered as a novel way towards treatment of vasculitis. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:459 / 461
页数:3
相关论文
共 39 条
  • [31] THE ARRANGEMENT OF THE IMMUNOGLOBULIN-LIKE DOMAINS OF ICAM-1 AND THE BINDING-SITES FOR LFA-1 AND RHINOVIRUS
    STAUNTON, DE
    DUSTIN, ML
    ERICKSON, HP
    SPRINGER, TA
    [J]. CELL, 1990, 61 (02) : 243 - 254
  • [32] Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules
    Tikellis, C.
    Jandeleit-Dahm, K. A.
    Sheehy, K.
    Murphy, A.
    Chin-Dusting, J.
    Kling, D.
    Sebokova, E.
    Cooper, M. E.
    Mizrahi, J.
    Woollard, K. J.
    [J]. ATHEROSCLEROSIS, 2008, 199 (01) : 55 - 64
  • [33] Antiadhesion molecule therapy in inflammatory bowel disease
    Van Assche, G
    Rutgeerts, P
    [J]. INFLAMMATORY BOWEL DISEASES, 2002, 8 (04) : 291 - 300
  • [34] Intercellular adhesion molecule-1
    vandeStolpe, A
    vanderSaag, PT
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (01): : 13 - 33
  • [35] RESIDUES WITHIN A CONSERVED AMINO-ACID MOTIF OF DOMAIN-1 AND DOMAIN-4 OF VCAM-1 ARE REQUIRED FOR BINDING TO VLA-4
    VONDERHEIDE, RH
    TEDDER, TF
    SPRINGER, TA
    STAUNTON, DE
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 125 (01) : 215 - 222
  • [36] Soluble ICAM-1: A marker of vascular inflammation and lifestyle
    Witkowska, AM
    [J]. CYTOKINE, 2005, 31 (02) : 127 - 134
  • [37] Wu Ted, 2005, Vasc Health Risk Manag, V1, P309, DOI 10.2147/vhrm.2005.1.4.309
  • [38] XU Y, BR J PHARM
  • [39] Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases
    Yusuf-Makagiansar, H
    Anderson, ME
    Yakovleva, TV
    Murray, JS
    Siahaan, TJ
    [J]. MEDICINAL RESEARCH REVIEWS, 2002, 22 (02) : 146 - 167